Supporting obesity treatment, major bleeds with anticoagulants and SSRIs, equity in COPD care

In this podcast recorded in early October, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the November issue of DTB. They provide an overview of the editorial that discusses the need to support people taking drugs to help with weight loss: "Providing the drug is only one part of the process and if the other elements are not available to support people with obesity the full benefits of these expensive treatments will not be realised" - . They talk about the results of an observational study that assessed the risk of major bleeds with concomitant use of selective serotonin reuptake inhibitors (SSRIs) and oral anticoagulants - . The main article discusses equity of care in the management of COPD and that those more at risk of COPD are also more likely to experience barriers to care - . They begin by highlighting two articles* in the BMJ that consider the problem of conflicts of interest. *Fabbri A, Grundy Q. Protecting early career physicians from commercial influence. BMJ. 2024 Sep 9;386:q1939. ( ) McCartney M. Transparency as a means to conquer conflicts of interest is illusory. BMJ. 2024 Sep 24;386:q2092. ( ) Please

You can listen to Supporting obesity treatment, major bleeds with anticoagulants and SSRIs, equity in COPD care online on Radio and Podcast. Open the player on this page to stream the available audio.

Supporting obesity treatment, major bleeds with anticoagulants and SSRIs, equity in COPD care is an episode from DTB podcast by BMJ Group.

This episode is 24:31 long.

This episode was published on Oct 30, 2024.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from DTB podcast when more episodes are available from the podcast feed.